Pancreatic Cancer Research

ResearcherChinese University of Hong KongNo recent work listed

Yinxin Zhu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5065308092. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper

Papers 4

  1. Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40364-023-00514-4↗
  2. LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jcmgh.2020.06.009↗
  3. Histone demethylase JMJD3 disrupts spectrin-dependent cytoskeleton in Pancreatic Ductal Adenocarcinoma cells by regulating H exokinase domain containing 1 expr… Co-author DOI 10.21203/rs.3.rs-30041/v1↗
  4. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Co-author DOI 10.1053/j.gastro.2013.01.058↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yangchao Chen · 4 shared papers, 2013–2023 · strength 0.44
  2. Chi Hin Wong · 2 shared papers, 2020–2023 · strength 0.30
  3. Chi Han Li · 3 shared papers, 2013–2020 · strength 0.24
  4. Jiatong Wang · 1 shared paper, 2023 · strength 0.19
  5. Zhangang Xiao · 2 shared papers, 2013–2020 · strength 0.14
  6. Huiyi Feng · 1 shared paper, 2020 · strength 0.11
  7. Guolin Li · 1 shared paper, 2020 · strength 0.11
  8. Rufu Chen · 1 shared paper, 2020 · strength 0.11
  9. Stephen Lam Chan · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.